Focus: Generate Biomedicines is a publicly-traded biotech focused on machine learning-driven therapeutic protein design, headquartered in Somerville, MA with 51-200 employees. The company leverages computational biology to generate novel protein therapeutics across respiratory, immunology, and oncology indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Growing — net +15 jobs in 30d
20 jobs added vs 5 removed. Steady team buildout.
Best suited for scientists and computational specialists seeking IP-driven platform innovation with public-market optionality, but hiring appears limited and commercial opportunities remain distant.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Generate Biomedicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Generate Biomedicines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo